CCI-779 in Treating Patients With Mantle Cell Non-Hodgkin's Lymphoma

Clinical trial NCT00033267 · COMPLETED

Trial details

NCT number: NCT00033267
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent Mantle Cell Lymphoma

Start date: 2002-04-01
Primary completion: 2006-02-01
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.